These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 367896)

  • 1. [Chemotherapy of malignant melanomas].
    Gallmeier WM
    Haematol Blood Transfus; 1978; 21():293-302. PubMed ID: 367896
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in the management of malignant melanoma.
    Lichtenfeld JL
    Am J Med Sci; 1976; 272(2):185-95. PubMed ID: 1008080
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy.
    Everall JD; Dowd PM
    Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
    [No Abstract]   [Full Text] [Related]  

  • 6. DTIC (NSC-45388) in malignant melanoma: a perspective.
    Comis RL
    Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of malignant melanoma].
    Wagenknecht L
    Schweiz Med Wochenschr; 1973 Oct; 103(41):1426-8. PubMed ID: 4127413
    [No Abstract]   [Full Text] [Related]  

  • 8. Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma.
    Aranha GV; Grage TB
    Minn Med; 1977 Aug; 60(8):543-8. PubMed ID: 882082
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of malignant melanoma].
    Karakousis CP
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma].
    Kogoniia LM; Moroz LV; Perevodchikova NI; Platinskiĭ LV; Borisov AI
    Vopr Onkol; 1981; 27(4):16-21. PubMed ID: 7015692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Melanoma therapy].
    Kleeberg UR
    Dtsch Med Wochenschr; 1976 Jun; 101(23):904-8. PubMed ID: 773624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of malignant melanoma].
    Veronesi U; Bajetta E
    Cancro; 1973; 26(5):307-13. PubMed ID: 4793832
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
    Mitchell MS; Mokyr MB; Davis JM
    J Clin Invest; 1977 Jun; 59(6):1017-26. PubMed ID: 863999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
    Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
    N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of malignant melanoma.
    Benjamin RS
    World J Surg; 1979 Jul; 3(3):321-8. PubMed ID: 382646
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
    Carmo-Pereira J; Oliveira Costa F; Pimentel P
    Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
    [No Abstract]   [Full Text] [Related]  

  • 18. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS; Neuberg D; Park Y; Kirkwood JM
    Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma.
    Comis RL; Carter SK
    Cancer Treat Rev; 1974 Dec; 1(4):285-304. PubMed ID: 4619579
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy in the treatment of malignant melanomas.
    Westbury G
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):445-7. PubMed ID: 274009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.